Provided by Tiger Trade Technology Pte. Ltd.

Immatics N.V.

8.75
-0.3600-3.95%
Pre-market: 8.50-0.2498-2.85%07:38 EDT
Volume:798.77K
Turnover:7.09M
Market Cap:1.31B
PE:-4.79
High:9.09
Open:9.02
Low:8.66
Close:9.11
52wk High:12.41
52wk Low:5.67
Shares:150.00M
Float Shares:83.07M
Volume Ratio:1.44
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8285
EPS(LYR):-1.8903
ROE:-47.80%
ROA:-26.92%
PB:2.83
PE(LYR):-4.63

Loading ...

Analysts Offer Insights on Healthcare Companies: Immatics (IMTX) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Jun 17

Immatics announces annual general meeting

Reuters
·
Jun 02

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

GlobeNewswire
·
Jun 01

Immatics announces presentation of extended data from Phase 1 trial of IMA401

TIPRANKS
·
Jun 01

Immatics announces updated Phase 1 data for its Prame TCR T-cell therapy

TIPRANKS
·
Jun 01

Immatics presents Phase 1 data for IMA401 MAGEA4/8 bispecific at ASCO 2026, supporting lung cancer combo study with IMA402

Reuters
·
May 31

Immatics posts ASCO presentation on PRAME-targeted TCR-T therapies in synovial sarcoma

Reuters
·
May 31

Immatics reports 63% response rate in Phase 1 trial of IMA203CD8 PRAME T-cell therapy in hard-to-treat gynecologic cancers

Reuters
·
May 30

Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting

GlobeNewswire
·
May 30

How Investors May Respond To Immatics (IMTX) Wider Q1 Loss And Rising Funding Needs

Simply Wall St.
·
May 21

Immatics Is Maintained at Buy by Chardan Capital

Dow Jones
·
May 20

Chardan Capital Reaffirms Their Buy Rating on Immatics (IMTX)

TIPRANKS
·
May 20

Immatics N.V. (NASDAQ:IMTX) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.
·
May 15

Analysts Offer Insights on Healthcare Companies: Immatics (IMTX) and Cormedix (CRMD)

TIPRANKS
·
May 15

Stock Track | Immatics Soars 5.18% in Pre-market After Goldman Sachs Maintains Buy Rating

Stock Track
·
May 13

Immatics (IMTX) Gets a Buy from Goldman Sachs

TIPRANKS
·
May 13

Immatics NV reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Immatics Q1 Loss Widens, Revenue Falls

MT Newswires Live
·
May 12

Immatics Q1 EPS $(0.50) Misses $(0.42) Estimate, Sales $8.914M Miss $14.590M Estimate

Benzinga Earnings
·
May 12

Earnings Flash (IMTX) Immatics Posts Q1 Net Loss 0.43 Euro a Share, vs. FactSet Est of 0.45 Euro Loss

MT Newswires Live
·
May 12